Häftad, Engelska, 2024

Cancer Epigenetics and Nanomedicine

Targeting the Right Player via Nanotechnology

Av Prashant Kesharwani, Chitra Thakur

2359 kr

Beställningsvara. Skickas inom 11-20 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Beskrivning

Cancer Epigenetics and Nanomedicine: Targeting the Right Player via Nanotechnology is a complete package that provides a comprehensive and thorough understanding of the key players that modulate the various steps of carcinogenesis and malignant progression of the disease and the critical targets to be exploited for developing novel modalities of diagnosis and therapeutics.

Since epigenetic aberrations can be potentially reversed and restored to their normal state through epigenetic therapy, the book also discusses the challenges and the future of the field with the cutting-edge revelations and limitations that this research endeavor can offer, thereby helping the readers to enhance their critical thinking and adopt strategies of therapeutic importance.

Delivers a detailed and complete journey of how cancer develops, its genetics, as well as other internal and external factors that are contributors of carcinogenesis
Provides in-depth knowledge on epigenetics and the various epigenetic biomolecules, enzymes, and other signaling pathways that are promising entities for drug discovery and chemotherapeutics
Presents state-of-the-art information on the next-generation cancer therapies, challenges, and future of the field

Produktinformation

Utgivningsdatum: 2024-07-02
Mått: 191 x 235 x 26 mm
Vikt: 950 g
Format: Häftad
Språk: Engelska
Antal sidor: 458
Förlag: Elsevier Science
ISBN: 9780443132094

Utforska kategorier

Mer information

Dr. Prashant Kesharwani, PhD, is an Assistant Professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr.Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research,and industrial experience across various countries. An overarching goal of his current research is the development ofnanoengineered drug delivery systems for various diseases. He has more than 400 international publications in well-reputedjournals and more than 30 international books (Elsevier). His work has garnered 40,000 + citations, with an h-index of above100, making him one of the youngest Indian researchers to achieve an h-index of 100 at the age of 41. He is a recipientof many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards,such as “USERN Laureate award and “SERB-Ramanujan Fellowship Award. He has presented many invited talks and oralpresentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution,supervised students/junior researchers, and actively participated in outreach and scientific dissemination for the service ofthe wider community. Dr. Chitra Thakur is an Assistant Professor-Research in the Department of Pathology at the Stony Brook Cancer Center, New York, USA. She is a cancer biologist and has expertise in molecular oncology, mouse models of human cancers, analyzing big data in translational research, toxicology, and epigenetics in human cancers. She is the recipient of several internationally acclaimed awards such as the “DFG German Excellence Initiative Award,, “NIH-Big Data Training for Translational Omics Research and “American Cancer Society IRG. With more than 45 research articles published in mainstream scientific journals, she has contributed significantly towards the understanding of the molecular mechanisms in human cancers. She is engrossed in cancer research, teaching, and community outreach initiatives, hence fostering the scientific community and health care professionals engaged in cancer diagnosis, and treatment.

Recensioner i media

Select Guide Rating

Butikslager

Ej i lager i butik.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.